The Antiviral Efficacy of <i>Withania somnifera</i>(Ashwagandha) against Hepatitis C Virus Activity: <i>In Vitro</i>and <i>in Silico</i>Study

作     者：Dina Mofed Wafaa Ahmed Abdel-Rahman Zekri Ola Said Mohamed Rahouma Ahmed Hassan Ibrahim Faraag Dina Mofed;Wafaa Ahmed;Abdel-Rahman Zekri;Ola Said;Mohamed Rahouma;Ahmed Hassan Ibrahim Faraag

作者机构：Biochemistry and Molecular Biology Unit Department of Cancer Biology National Cancer Institute Cairo University Cairo Egypt Immunity and Virology Unit Department of Cancer Biology National Cancer Institute Cairo University Cairo Egypt Department of Surgical Oncology National Cancer Institute Cairo University Cairo Egypt Department of Botany and Microbiology Faculty of Science Helwan University Cairo Egypt 

出 版 物：《Advances in Microbiology》 (微生物学（英文）)

年 卷 期：2020年第10卷第9期

页      面：463-477页

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 100401[医学-流行病与卫生统计学] 10[医学] 

主　　题：Antiviral Ashwagandha Hepatitis C Virus Docking Lymphocyte 

摘      要：Objective: Evaluation antiviral effects of Withania somnifera (Ashwagandha) leaf extract against HCV. Methods: cell proliferation was assessed using MTT assay after isolation of lymphocyte cells and treated with Ashwagandha water extract (ASH-WX) (6.25 mg/ml - 100 mg/ml). Assessment of quantitative Real-time PCR, Colony forming assay, TNF-α and molecular docking studies after infection of normal lymphocyte cells with 1 ml (1.5 × 106 HCV) serum then incubated with ASH-WX at concentration 25 mg/ml & 50 mg/ml. Results: MTT assay revealed a significant increase (p α significantly decreased following ASH-WX treatment compared with control untreated infected cells (p 3 IU/mL. Colony formation assay test revealed colony formation reduction compared to positive untreated control. Molecular docking analysis revealed good prediction of binding between Ashwagandha and NS5B and PKN2 compared to Sovaldi. Conclusion: ASH-WX may be a powerful antiviral against HCV infection.